9. References

1. Study on off-label use of medicinal products in the European Union, NIVEL, Dutch National Institute for Public Health and the Environment, and the European Public Health Alliance, 2017.

2. Declaration on Good Off-Label Use Practice ‘Promoting Good Practice for the off-label use of medicines’, European Brain Council et al., 2021

3. New Early Access and Off-Label Use Rules in France, Léna Beley et al., July 6, 2021, Posted in Compassionate Use, European Union, Healthcare system, Medicinal Products, Pharmaceutical companies

4. Ciênc. saúde coletiva 25 (9) Sept 2020 https://www.scielo.br/j/csc/a/GQwLcBQZmGYp7mK3V6r7tFt/?lang=en&format=pdf

5. ADDRESSING CHALLENGES IN ACCESS TO ONCOLOGY MEDICINES © OECD 2020
https://www.oecd.org/health/health-systems/Addressing-Challenges-in-Access-to-Oncology-Medicines-Analytical-Report.pdf